Back |
home / stock / ccxi / ccxi message board
Subject | By | Source | When |
---|---|---|---|
chartguy89: CCXI 8.89 Chemocentryx Inc Stock Charts $CCXI Last Updated: 03/13/15 Last price: 8.89 To | chartguy89 | investorshangout | 03/14/2015 12:04:08 AM |
clayton: CCXI 8.89 Chemocentryx Inc $CCXI stock added to my watch list. Right now with CCXI I am wat | clayton | investorshangout | 03/13/2015 11:24:20 PM |
danrocks: CCXI Stock is number 242 for the largest percentage gain out of 250 stocks. $CCXI CCXI is | danrocks | investorshangout | 02/19/2015 7:56:01 PM |
danrocks: CCXI Stock is number 94 for the largest percentage gain out of 250 stocks. $CCXI CCXI is u | danrocks | investorshangout | 12/10/2014 4:51:17 PM |
Emylers: CCXI 4.23 Chemocentryx Inc $CCXI Hit a 52 week low of 4.07 Closing the day 10:40 at 4.23 +0 | Emylers | investorshangout | 12/05/2014 4:17:35 PM |
danrocks: Right now CCXI is number 103 for the largest percentage gain out of 250 stocks. $CCXI CCXI | danrocks | investorshangout | 11/14/2014 5:09:35 PM |
News, Short Squeeze, Breakout and More Instantly...
AMGEN SUCCESSFULLY COMPLETES ACQUISITION OF CHEMOCENTRYX PR Newswire TAVNEOS ® (avacopan), a First-in-Class Medicine for Patients With Severe Active ANCA-Associated Vasculitis, Added to Inflammation Portfolio THOUSAND OAKS, Calif. , Oct. 20, ...
-- Planned posters and an oral presentation will highlight data from the trials that supported the approval of TAVNEOS ® (avacopan) for patients with ANCA-associated vasculitis; additional poster will cover expression of kidney C5aR -- SAN CARLOS, Calif., Oct. 17,...
-- Two poster presentations planned for CCX559, including results from ongoing Phase I clinical study in patients with advanced solid tumors, and preclinical evidence from murine model -- SAN CARLOS, Calif., Oct. 05, 2022 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (Nasdaq: CCXI), tod...